225 related articles for article (PubMed ID: 23817808)
1. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
2. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
3. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.
Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L
PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas.
Gu J; Zhang C; Chen R; Pan J; Wang Y; Ming M; Gui W; Wang D
Eur J Pediatr; 2009 Jun; 168(6):705-10. PubMed ID: 18795327
[TBL] [Abstract][Full Text] [Related]
7. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
[TBL] [Abstract][Full Text] [Related]
8. Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression.
Ke HL; Ke RH; Li ST; Li B; Lu HT; Wang XQ
J Neurooncol; 2013 Jun; 113(2):327-32. PubMed ID: 23525949
[TBL] [Abstract][Full Text] [Related]
9. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Kachra Z; Beaulieu E; Delbecchi L; Mousseau N; Berthelet F; Moumdjian R; Del Maestro R; Béliveau R
Clin Exp Metastasis; 1999; 17(7):555-66. PubMed ID: 10845554
[TBL] [Abstract][Full Text] [Related]
11. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
12. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
13. The expression of hypoxia-inducible factor-1 in primary brain tumors.
Reszec J; Rutkowski R; Chyczewski L
Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771
[TBL] [Abstract][Full Text] [Related]
14. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
15. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
Du Z; Abedalthagafi M; Aizer AA; McHenry AR; Sun HH; Bray MA; Viramontes O; Machaidze R; Brastianos PK; Reardon DA; Dunn IF; Freeman GJ; Ligon KL; Carpenter AE; Alexander BM; Agar NY; Rodig SJ; Bradshaw EM; Santagata S
Oncotarget; 2015 Mar; 6(7):4704-16. PubMed ID: 25609200
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
[TBL] [Abstract][Full Text] [Related]
18. mTORC1 inhibitors suppress meningioma growth in mouse models.
Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
[TBL] [Abstract][Full Text] [Related]
19. RRP22: a novel neural tumor suppressor for astrocytoma.
Chen R; Yang L; Fang J; Huo L; Zhang M; Chen F; Liu J; Wu J; Wang Y
Med Oncol; 2012 Mar; 29(1):332-9. PubMed ID: 21264544
[TBL] [Abstract][Full Text] [Related]
20. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
